Tocilizumab in COVID-19 management: addressing time of starting treatment. | Eur J Hosp Pharm;2022 Jan 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Tocilizumab in COVID-19 management: addressing time of starting treatment.

Khiali, Sajad; Entezari-Maleki, Taher.

Khiali S; Tabriz University of Medical Sciences, Tabriz, Iran.
Entezari-Maleki T; Tabriz University of Medical Sciences, Tabriz, Iran tentezari@gmail.com.

Eur J Hosp Pharm ; 2022 Jan 06.

Article in English | MEDLINE | ID: covidwho-2266258

Keywords

COVID-19; complementary therapies; critical care; pulmonary medicine; virology

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2022 Document Type: Article Affiliation country: Ejhpharm-2021-003149

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2022 Document Type: Article Affiliation country: Ejhpharm-2021-003149